Skip to main content Skip to search Skip to main navigation
News: Europe

EU: Procedures on Inspections and Exchange of Information in new Version 18

The European Commission has revised and restructured the Compilation of Community Procedures on Inspections and Exchange of Information. In addition to new content and editorial adjustments, the 295-page document has been divided into a Part I including procedural topics and a Part II containing interpretation documents and templates. The documents were last updated in 2014.

The compilation primarily serves a harmonised approach and to facilitate cooperation for inspections within the European Member States. It applies to both GMP and GDP inspections. The procedures outlined in the compilation in turn form the basis for national procedures that are part of the quality management systems of the national GMP inspectorates.

In Part I, these procedural topics have been revised in form of independent short documents:

  • Management and classification of reports of suspected quality defects in medicinal products and risk-based decision-making (new: provides more comprehensive guidance following quality risk management principles)
  • Procedure for managing rapid alerts arising from quality defects risk assessment
    (new: provides more comprehensive guidance following quality risk management principles)
  • Outline of a Procedure for Co-ordinating the Verification of the GMP Status of Manufacturers in Third Countries
  • The Issue and Update of GMP Certificates
  • A model for risk based planning for inspections of pharmaceutical manufacturers
  • Procedure for dealing with serious GMP non-compliance requiring co-ordinated measures to protect public or animal health (Procedure has been revised as a result of experience with the superseded procedure; Appendix 6: Supervisory Risk Assessment has been updated)
  • Procedure for dealing with serious GMP non-compliance information originating from third country authorities or international organisations

New in Part I:

  • Procedure for compliance management

In Part II revised interpretational documents and templates are:

  • Interpretation of the Union format for Manufacturer/Importer Authorisation
  • Interpretation of the Union format for GMP certificate
  • Interpretation of the Union format for a wholesale distribution authorisation (medicinal products for human use)
  • Union format for a GMP certificate
  • Statement of non-compliance with GMP

New in Part II:

  • Interpretation of the Union format for a wholesale distribution authorization (medicinal products for human use)

Source:
EU: CoCP on Inspections and Exchange of Informations

 

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may Also be Interested in the Following Articles

News: Medical Devices

EMA: Harmonisation of Combination-Product Quality Assessment

EMA’s Combination Products Operational Group (COMBO) is working to improve alignment between notified body opinions (NBOps) and pharmaceutical quality assessment, according to its report on the meeting held on 8 October 2026.
Read more
PIC/S: Revision of the Framework for International Cooperation

PIC/S: Revision of the Framework for International Cooperation

PIC/S has revised the framework governing its international cooperation. The updated Pharmaceutical Inspection Co-operation Scheme, PIC/S 1/95 (Rev. 7), was adopted in Istanbul on 2 November 2026 and entered into force on the same day.
Read more
FDA Updates Framework for Coordinating Facility Evaluations and Inspections

FDA Updates Framework for Coordinating Facility Evaluations and Inspections

FDA has revised its framework for collaboration between the Center for Drug Evaluation and Research (CDER) and the Office of Inspections and Investigations (OII). Version 2.0 of the Concept of Operations (ConOps), effective October 21, 2026, supersedes the original June 2017 version.
Read more
Outsourced Activities in the GDP Environment Part III: Contract Giver and Contract Acceptor

Outsourced Activities in the GDP Environment Part III: Contract Giver and Contract Acceptor

For any outsourced GDP activity, there is a need for delimitation of responsibilities between a client (contract giver) and a contractor (contract acceptor). Read more about their roles and responsibilities in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
Question of the Week | GMP-Verlag

Who is Qualified to Conduct Self-Inspections within a Company?

Here's the question:
Read more
News: Europe

EU: Singapore Added to List of Recognised Third Countries for API Importation

The European Commission recognises Singapore’s GMP requirements and regulatory oversight of active substance manufacturers as equivalent to EU requirements. Once the decision enters into force (15 November), Singapore will join the EU list of recognised third countries for the importation of active substances.
Read more
Previous
Next